Michael Wessolly

13PUBLICATIONS
26CO-AUTHORS
Cancer cell biologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Feb 24, 2024
The Impact of Cancer-Associated Fibroblasts on the Biology and Progression of Colorectal Carcinomas.

Larissa Maria Henrich, Kristina Greimelmaier, Michael Wessolly

|Aug 12, 2023
Cancer-Associated Fibroblasts Influence Survival in Pleural Mesothelioma: Digital Gene Expression Analysis and Supervised Machine Learning Model.

Sabrina Borchert, Alexander Mathilakathu, Alina Nath

|Aug 12, 2023
Complete Metabolic Response to Combined Immune Checkpoint Inhibition after Progression of Metastatic Colorectal Cancer on Pembrolizumab: A Case Report.

Carolin Krekeler, Klaus Wethmar, Jan-Henrik Mikesch

|Jul 14, 2023
Integrated Clinical, Molecular and Immunological Characterization of Pulmonary Sarcomatoid Carcinomas Reveals an Immune Escape Mechanism That May Influence Therapeutic Strategies.

Susann Stephan-Falkenau, Anna Streubel, Thomas Mairinger

|Apr 13, 2023
One Third of Malignant Pleural Mesothelioma Shows High Immunohistochemical Expression of MSLN or CXCR4 Which Indicates Potent Candidates for Endo-Radiotherapy.

Thomas Hager, Sabrina Borchert, Michael Wessolly

|Oct 27, 2022
Landscape of Genomic Alterations and PD-L1 Expression in Early-Stage Non-Small-Cell Lung Cancer (NSCLC)-A Single Center, Retrospective Observational Study.

Susann Stephan-Falkenau, Anna Streubel, Thomas Mairinger

Pageof 3

Frequent Collaborators

8 joint publications

Fabian Dominik Mairinger

7 joint publications

Sabrina Borchert

4 joint publications

Jeremias Wohlschlaeger

3 joint publications

Kurt Werner Schmid